Valion Bio (VBIO) EBITDA Margin (2021 - 2025)
Valion Bio's EBITDA Margin was -1700.68% in Q3 2025, down 565.76 percentage points from -1134.92% a year earlier but up 249.32 percentage points from the prior quarter.
Powered by 
Analysis
Valion Bio (VBIO) EBITDA Margin (2021 - 2025) Analysis & Trends
On a trailing twelve-month basis, Valion Bio's EBITDA Margin was -1237.14% through Sep 30, 2025, down 566.60 percentage points year-over-year; for FY2024, it came in at -573.46%, up 126.96 percentage points from FY2023.
- EBITDA Margin shows a three-year change of -125.97 percentage points (FY2021 to FY2024).
- In earlier years, EBITDA Margin was -700.43% in FY2023 (-152.16 pp), -548.26% in FY2022 (-100.77 pp) and -447.49% in FY2021.
- Quarterly EBITDA Margin has moved between -2150.00% (Q1 2025) and -165.56% (Q4 2024) over five years.
- Compared with a year earlier, EBITDA Margin has declined for three straight quarters, with an average year-over-year change of -363.75 percentage points over the last eight quarters.
- The best year-over-year quarter for EBITDA Margin over five years was Q4 2024 (a gain of 462.46 percentage points); the worst was Q1 2025 (a drop of 1706.89 percentage points).
- Per Business Quant data, VBIO's EBITDA Margin in the three quarters before Q3 2025 was -1950.00% (Q2 2025), -2150.00% (Q1 2025) and -165.56% (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 42.49% |
| 10 | Valion Bio | 73,008.00 | -25.39 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -1,700.68% |
| Jun 30, 2025 | -1,950.00% |
| Mar 31, 2025 | -1,965.71% |
| Dec 31, 2024 | -165.56% |
| Sep 30, 2024 | -1,134.92% |
| Jun 30, 2024 | -903.57% |
| Mar 31, 2024 | -443.11% |
| Dec 31, 2023 | -628.01% |
| Sep 30, 2023 | -623.76% |
| Jun 30, 2023 | -1,318.01% |
| Mar 31, 2023 | -562.23% |
| Dec 31, 2022 | -552.21% |
| Sep 30, 2022 | -541.09% |
| Jun 30, 2022 | -571.21% |
| Mar 31, 2022 | -523.13% |
| Dec 31, 2021 | -554.24% |
| Sep 30, 2021 | -29.96% |
| Jun 30, 2021 | -315.30% |
| Mar 31, 2021 | -245.82% |
API Access
Valion Bio EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=VBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "VBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=VBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();